ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)

KOSDAQ:034940 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,097	2,047	4,526	5,749	4,164
Short-Term Investments	2,549	1,538	1,537	1,587	1,706
Trading Asset Securities	800.73	775.02	2,386	2,849	3,176
Cash & Short-Term Investments	5,447	4,361	8,449	10,184	9,046
Cash Growth	24.93%	-48.39%	-17.04%	12.59%	-37.57%
Accounts Receivable	18,250	20,230	22,727	20,884	21,546
Other Receivables	1,818	2,593	2,731	2,359	2,024
Receivables	20,948	23,900	27,603	24,867	25,039
Inventory	12,446	13,012	10,869	10,286	12,581
Prepaid Expenses	204.88	87.45	94.42	118.8	86.24
Other Current Assets	693.01	796.44	1,183	1,048	597.9
Total Current Assets	39,740	42,157	48,200	46,504	47,350
Property, Plant & Equipment	19,712	20,370	24,999	24,074	22,190
Long-Term Investments	3,068	2,792	2,935	3,678	3,163
Goodwill	-	-	-	46.78	46.78
Other Intangible Assets	769	803.4	806.87	795.5	583.5
Long-Term Accounts Receivable	0	1,054	1,054	-	-
Long-Term Deferred Tax Assets	1,370	1,499	1,401	945.32	1,671
Other Long-Term Assets	6,662	5,544	6,028	4,049	6,377
Total Assets	71,320	74,221	85,639	80,512	82,377
Accounts Payable	4,865	5,501	4,994	3,685	3,599
Accrued Expenses	3,516	3,494	2,765	2,775	2,664
Short-Term Debt	20,750	14,550	14,554	12,794	4,450
Current Portion of Long-Term Debt	448.61	-	-	-	3,700
Current Portion of Leases	629.07	633.15	637.5	684.07	745.25
Current Unearned Revenue	140.5	153.42	122.27	88.1	125.71
Other Current Liabilities	6,306	4,847	4,255	4,236	3,894
Total Current Liabilities	36,656	29,178	27,328	24,263	19,178
Long-Term Debt	1,576	1,105	1,904	1,000	-
Long-Term Leases	1,285	1,213	1,583	1,996	1,350
Other Long-Term Liabilities	1,941	3,422	3,417	3,542	3,615
Total Liabilities	42,759	35,464	34,231	32,129	25,634
Common Stock	15,490	15,490	15,490	15,490	15,490
Additional Paid-In Capital	63,621	63,621	63,621	63,621	63,502
Retained Earnings	-47,817	-38,175	-26,354	-29,255	-20,640
Comprehensive Income & Other	81.67	57.07	86.29	64.05	-50.28
Total Common Equity	31,376	40,993	52,844	49,920	58,302
Minority Interest	-2,815	-2,235	-1,436	-1,537	-1,559
Shareholders' Equity	28,561	38,758	51,408	48,383	56,743
Total Liabilities & Equity	71,320	74,221	85,639	80,512	82,377
Total Debt	24,689	17,501	18,678	16,474	10,245
Net Cash (Debt)	-19,242	-13,141	-10,229	-6,289	-1,199
Net Cash Per Share	-621.05	-423.67	-330.17	-203.02	-38.71
Filing Date Shares Outstanding	30.99	30.98	30.98	30.98	30.98
Total Common Shares Outstanding	30.99	30.98	30.98	30.98	30.98
Working Capital	3,084	12,979	20,872	22,242	28,172
Book Value Per Share	1012.46	1323.22	1705.75	1611.38	1881.94
Tangible Book Value	30,607	40,190	52,037	49,078	57,672
Tangible Book Value Per Share	987.64	1297.29	1679.70	1584.20	1861.59
Land	8,811	8,864	9,408	9,329	7,060
Buildings	14,756	14,739	18,178	18,129	17,637
Machinery	30,693	30,233	26,893	26,807	27,563
Construction In Progress	-	7.24	4,157	1,430	191.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.